| DNLYX | VIMAX | DNLYX / VIMAX | |
| Total Expense Ratio | 0.75 | 0.05 | 1,500% |
| Annual Report Gross Expense Ratio | 0.86 | 0.05 | 1,720% |
| Fund Existence | 10 years | 24 years | - |
| Gain YTD | 9.487 | 9.983 | 95% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 3000 | 33,333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 478M | 199B | 0% |
| Annual Yield % from dividends | 0.96 | 1.48 | 65% |
| Returns for 1 year | -4.79 | 2.45 | -195% |
| Returns for 3 years | 21.08 | 34.59 | 61% |
| Returns for 5 years | 16.29 | 44.96 | 36% |
| Returns for 10 years | 12.51 | 139.14 | 9% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FBT | 211.17 | 1.19 | +0.57% |
| First Trust NYSE Arca Biotech ETF | |||
| BLGR | 29.31 | 0.14 | +0.49% |
| Bluemonte Large Cap Growth ETF | |||
| EMF | 17.04 | 0.04 | +0.24% |
| Templeton Emerging Markets Fund | |||
| NEWZ | 27.52 | 0.02 | +0.07% |
| EA Series Trust StockSnips AI-Powered Sentiment US All Cap ETF | |||
| RSF | 14.40 | -0.04 | -0.28% |
| RiverNorth Capital and Income Fund | |||